DIFGEN PHARMACEUTICALS RECEIVES FDA CLEARANCE TO BEGIN CLINICAL DEVELOPMENT FOR A SINGLE INJECTION TREATMENT FOR ADVANCED BREAST CANCER DFGN-101

Reuters · 3d ago

Please log in to view news